Approach to the Patient with Functional Gastrointestinal Disease



Approach to the Patient with Functional Gastrointestinal Disease


James M. Richter



Functional gastrointestinal (GI) disease accounts for a large proportion of the GI complaints seen in office practice, not only in the primary care setting but also in the referral practices of gastroenterologists. The International Working Group consensus definition of functional GI disease refers to “a variable combination of chronic or recurrent GI symptoms not explained by structural or biochemical abnormalities.” Symptoms may be attributed to dysfunction of the pharynx, esophagus, stomach, biliary tree, small and large intestine, or anorectum. Included under the rubric of functional GI disease are two common, often-troubling syndromes: irritable bowel syndrome (IBS) and nonulcer dyspepsia. The former is associated with large-bowel discomfort or pain, disturbed defecation, and distention, often with predominant constipation, diarrhea, or gaseousness. The latter is characterized by upper abdominal discomfort, bloating, distension, and nausea, which is often, but not necessarily, exacerbated or triggered by eating.

The primary care physician needs to be expert in the recognition and management of these conditions not only because they can mimic more serious disease (sometimes leading to unnecessary testing and treatment) but also because they are the source of much worry, functional impairment, and substantial health care expenditures.


IRRITABLE BOWEL SYNDROME

IBS is a functional disturbance of intestinal motility and visceral perception. It accounts for about half of GI complaints seen by physicians. Epidemiologic studies suggest that nearly 20% of adults suffer from some form of the condition, although only a fraction seeks medical attention. Functional bloating, functional constipation, and functional diarrhea are closely allied syndromes that are beginning to be separated from IBS. Older and
lay terms sometimes used synonymously include spastic bowel, mucous colitis, and spastic colitis. Because there are no definitive diagnostic tests, the identification of the condition requires taking a careful history to avoid misdiagnosis.


Pathophysiology and Clinical Presentation (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 and 17)



Clinical Presentation and Course

Most patients experience the onset of symptoms well before age 40 years; about one half are younger than 30 years, and one fourth are younger than 20 years. The combination of abdominal pain and diarrhea and/or constipation helps to differentiate IBS from other forms of functional GI disease, in which only one feature is present. In about two thirds of IBS patients, either diarrhea or constipation may predominate.

Abdominal pain or discomfort is almost universal. In two thirds of patients, abdominal pain is reported most often in the left lower quadrant or lower abdomen; one third note upper abdominal pain, and one fourth experience it in multiple sites. The pain is typically achy rather than crampy and is often relieved by a bowel movement or the passage of flatus, and it usually does not disturb sleep. Pain radiation is variable and can extend into the left chest and arm when gas is trapped in the splenic flexure.

Constipation is a prominent complaint, characterized by small, hard, infrequent stools and an empty rectal ampulla. Prolonged retention of stool allows the full absorption of intestinal water content. About one third of patients report mucous stools, pellet-like stools, and/or excessive flatus. A constipationpredominant form of IBS occurs in about one third of patients, more commonly in men.

Diarrhea characteristically alternates with constipation; in about 10% of patients, diarrhea is the sole manifestation. The diarrhea is typically small in volume, associated with visible
amounts of mucus, and may follow a hard movement by a few hours. There may be urgency. In about one third of patients, a diarrhea-predominant form of IBS is noted, more frequently in women.

Dyspepsia and excessive eructation are also reported, supporting the view of a process that involves the entire GI tract. Weight loss is rare. Intercurrent infectious gastroenteritis may trigger an exacerbation. Fifty percent of patients consider their symptoms to be related to stress, whereas one third deny it. Two thirds manifest symptoms of anxiety or depression. Rectal bleeding is absent unless there is coincident hemorrhoidal disease.

Chronicity is the rule, with little change in symptoms over time, except for waxing and waning. Duration is measured in years. There is no evidence of significant morbidity or mortality. Severity waxes and wanes, but the constellation of symptoms remains remarkably constant. In natural history studies, about 50% of patients are unchanged at 1 year, about 30% to 35% are improved (10% symptom-free), and 15% to 20% are worse. The symptom-free period is usually less than a few months. One third of employed IBS patients lose time from work. At 2 years of follow-up, a similar pattern is found. Persons with symptoms triggered by a major life stress enjoy long symptom-free periods after the acute problem abates, whereas those with continuous intestinal complaints in response to daily living rarely became asymptomatic.


Diagnosis and Initial Evaluation (4,6,13,18, 19, 20, 21, 22, 23, 24 and 25)


Clinical Criteria for Diagnosis of IBS

The lack of an objective laboratory marker for IBS necessitates clinical criteria for diagnosis. The two most widely used and best-validated sets of criteria are those specified by Manning et al. in the late 1970s and the subsequently developed Rome Diagnostic Criteria (Table 74-1). These symptom-based criteria have been largely validated and are widely used for suggesting the diagnosis of IBS.

Although the sensitivity and specificity of the Manning criteria have, for the most part, been confirmed, there are some questions regarding the discriminating value of individual items. Consequently, the Rome Diagnostic Criteria were developed to overcome some of the shortcomings of the Manning criteria and are often used for patient selection in clinical studies.








TABLE 74-1 Diagnostic Criteria for IBS
























Manning Criteria



▪ Continuous or recurrent symptoms during several months of abdominal pain or discomfort relieved with defecation or associated with a change in frequency or consistency of stool and/or



▪ An irregular or varying pattern of disturbed defecation at least 25% of the time, consisting of two or more of the following: altered frequency; altered consistency; straining, urgency, or feeling of incomplete evacuation; passage with mucus; and bloating or feeling of distention


Rome Criteria



▪ Recurrent abdominal pain or discomfort at least 3 d/mo for the past 3 mo and onset at least 6 mo before diagnosis, associated with two or more of the following:




• Improvement with defecation


• Onset associated with a change in frequency of stool


• Onset associated with a change in form (appearance) of stool


Manning criteria from Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel syndrome. BMJ 1978;2:653, with permission from BMJ Publishing Group Ltd.


Rome criteria: Adapted from Mayer EA. Irritable bowel syndrome. N Engl J Med 2008;358:1692; based on Longstreth GF, Thompson WG, Chey WD,” et al. Functional bowel disorders. In Drossman DA, Corazziari E, Spiller R, et al., eds. Rome III: the functional gastrointestinal disorders, 3rd ed. McLean, VA: Degnon, 2006:487, with permission.


Some clinical situations require ruling out organic pathology that might resemble and be mistaken for IBS (see later discussion). Detailed history taking and careful physical examination, combined with selective parsimonious testing and a few diagnostic trials of therapeutic measures, will usually provide the best combination of completeness and cost efficacy.


Subgroups

Based on clinical presentation, subgroups are designated: IBS with diarrhea predominant, IBS with constipation predominant, and IBS with mixed bowel habits.


Differential Diagnosis and Overall Approach to Workup

Colon cancer, inflammatory bowel disease, celiac sprue, and ovarian cancer are the principal “must-not-miss” conditions that may mimic the presentation of IBS. Concern about such etiologies often precipitates the patient’s coming for evaluation. A detailed initial history and careful physical examination supplemented by a few simple laboratory studies (e.g., complete blood count) can address the diagnostic criteria for IBS and check for warning signs of more serious disease, helping to differentiate the IBS patient from one who needs more extensive workup for a mimicking must-not-miss condition. Colonoscopy and other expensive testing are not required for diagnosis unless symptoms and signs of worrisome pathology are elicited. Prospective studies with up to 30 years of follow-up for such an approach to IBS workup have shown only a 1% rate of missing the mustnot-miss conditions.


Alarm Symptoms.

Attention to the so-called alarm symptoms (weight loss, evidence of GI blood loss, anemia, fever, frequent nocturnal symptoms, positive family history of colon cancer, onset after age 50 years, sudden change in symptoms) helps to screen for the mustnot-miss conditions. Persons with IBS-like symptoms manifesting one of the alarm “symptoms” should not be labeled as having IBS until more extensive testing is conducted (see later discussion and also Chapters 58, 64, and 65).


When Constipation Predominates.

In this setting, it may be necessary to rule out a malignancy and Crohn disease, particularly in patients older than the age of 40 years who have an alarm symptom such as weight loss or a family history of colon cancer. In such patients, one needs to consider colonoscopy (see Chapter 65). In young persons, a stool test for occult blood and a complete blood count (for microcytic anemia) should suffice. The absence of evidence for GI blood loss helps to exclude organic disease. A test of thyroid-stimulating hormone is indicated to rule out hypothyroidism, which also may present as constipation. Patients taking diuretics should have serum potassium checked because hypokalemia may reduce bowel contractility and produce an ileus. A clinical trial of increased dietary fiber or an osmotic laxative (psyllium) complements the diagnostic assessment.


When Diarrhea Predominates.

Here, it is important to be sure that there are no symptoms suggestive of celiac sprue, inflammatory disease, and other important causes of chronic diarrhea (see Chapter 64). Once completed, a dietary review can be helpful, especially for evidence of intolerance to lactose or sorbitol. A check of blood sugar is needed to rule out diabetes mellitus (which may present as diarrhea due to diabetic gastroenteropathy; see Chapter 102), as is a check of the stool for ova and parasites. A diagnostic trial of eliminating sorbitol-containing candies and restricting lactose-containing milk products (yogurt containing live cultures is relatively lactose-free) helps to rule out contributions from intraluminal factors. A lactose hydrogen breath test is an
alternative means of testing for lactose intolerance. A trial of the bile acid-binding resin cholestyramine serves as a simple test for bile acid malabsorption.

If diarrhea persists undiagnosed, a colonoscopy with or without mucosal biopsy might be reasonable to exclude inflammatory bowel disease and collagenous and lymphocytic forms of colitis (see Chapter 64). Because the clinical presentation can be mimicked by celiac sprue, testing for antiendomysial and/or tissue transglutaminase antibodies (see Chapter 64) is indicated when the possibility cannot be ruled out clinically; sensitivity is greater than 90% for these immunoglobulin A antibodies (see Chapter 64).


When Abdominal Pain, Distention, and Bloating Predominate.

In this setting, intermittent bowel obstruction, inflammatory bowel disease, celiac sprue, and pelvic pathology (especially ovarian carcinoma and endometriosis) require consideration. A plain film of the abdomen during an attack of severe pain should suffice to rule out obstruction. A complete blood count also helps to check for significant underlying bowel pathology. A negative serum determination for antiendomysial antibodies eliminates concern for celiac disease, especially when there is concurrent anemia. Transvaginal ultrasound is indicated when symptoms are of new onset or of increased frequency (almost daily) or severity, especially if they are accompanied by urinary tract or pelvic complaints (see Chapter 58). Such bloating and discomfort may also occur with lactose, fructose, or sorbitol intolerance, which can be tested for as detailed.


Psychological Assessment

Because underlying psychopathology is common in patients with IBS, therapy often requires identifying and addressing the patient’s psychological difficulties. In the context of conducting a thorough workup, the clinician needs sensitively to elicit details of the patient’s life situation, aspirations, accomplishments, frustrations, and losses. Concerns, fears, expectations, and responses to previous life stresses can also be very informative, as can the mental status of the patient on examination. Anxiety disorders are commonly identified (see Chapter 226), but depression (see Chapter 227) and somatization (see Chapter 230) often go unrecognized.

Aug 23, 2016 | Posted by in CRITICAL CARE | Comments Off on Approach to the Patient with Functional Gastrointestinal Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access